Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey-Reference-Cited by-同舟云学术

Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey

Published:2018-08 Issue: Volume:40 Page:45-52
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Bonotto Marta,Basile Debora,Gerratana Lorenzo,Pelizzari Giacomo,Bartoletti Michele,Vitale Maria Grazia,Fanotto Valentina,Lisanti Camilla,Mansutti Mauro,Minisini Alessandro Marco,Aprile Giuseppe,De Laurentiis Michele,Montemurro Filippo,Del Mastro Lucia,Puglisi Fabio

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference28 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2017

2. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer;Chia;Cancer,2007

3. Measures of outcome in metastatic breast cancer: insights from a real-world scenario;Bonotto;Oncol,2014

4. Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: a propensity score analysis;Bonotto;Breast,2017

5. Metastatic breast cancer: are we treating the same patients as in the past?;Ufen;Ann Oncol Off J Eur Soc Med Oncol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis;Cancers;2023-02-12

2. A novel antitumor protein from the mushroom Pholiota nameko induces apoptosis of human breast adenocarcinoma MCF-7 cells in vivo and modulates cytokine secretion in mice bearing MCF-7 xenografts;International Journal of Biological Macromolecules;2020-12

3. Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study;Future Oncology;2020-09

4. Optimal frequency of scans for patients on cancer therapies: A population kinetics assessment;Cancer Medicine;2019-09-27